Expertise in
9
conditions

Patrizia Bonadonna

Verona, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Verona, IT 

Overview

Patrizia Bonadonna practices in Verona, Italy. Ms. Bonadonna is highly rated in 9 conditions, according to our data. Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Anaphylaxis, and Hereditary Alpha-Tryptasemia.

Her clinical research consists of co-authoring 144 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

Verona, Italy
Other Locations
Vicenza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
Enrollment Status: Recruiting
Publish Date: January 30, 2026
Intervention Type: Drug
Study Drug: BLU-263
Study Phase: Phase 2/Phase 3
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 2
View 1 Less Clinical Trial

144 Total Publications

Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data.
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: September 09, 2025

Frequently Asked Questions about Patrizia Bonadonna

Is Patrizia Bonadonna a top-rated expert for Mast Cell Activation Syndrome (MCAS)?

MediFind is an objective health platform that identifies experts based on real-world data. Patrizia Bonadonna is classified as an Elite expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Patrizia Bonadonna participate in research or clinical trials?

Yes. Patrizia Bonadonna has published 144 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Patrizia Bonadonna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bonadonna's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile